EPIDEMIOLOGIC ANTECEDENTS OF PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN

Linda J Van Marter,Alan Leviton,Marcello Pagano,Elizabeth N Allred
DOI: https://doi.org/10.1203/00006450-199211000-00185
IF: 3.953
1992-11-01
Pediatric Research
Abstract:Despite the clinical and public health significance of Persistent Pulmonary Hypertension of the Newborn (PPHN), little is known about the syndrome's epidemiologic origins. Between July 1985 and April 1989 we interviewed a total of 103 mothers of case and 309 mothers of control infants who were hospitalized at two Harvard-affiliated neonatal intensive care units. A priori hypotheses focused on events linked to three potential pathophysiologic events: 1) inhibition of prostaglandin synthesis (i.e., maternal intake of aspirin and nonsteroidal anti-inflammatory agents [NSAIDs]), 2) fetal hypoxemia (i.e., maternal cigarette and marijuana smoking), and 3) vasospasm (i.e., maternal cocaine abuse). Two of our principal hypotheses were supported: odds ratios [OR] (95% confidence intervals [CI]) for the variables of greatest interest were: smoking=2.0 (1.2, 3.4), NSAIDs=3.6 (1.3, 10.3), aspirin products=2.1 (.89, 5.1), and illicit drugs=2.6 (.88, 7.7). Very low prevalence of confessed illicit drug use among our subjects precluded drug-specific analyses. We have tested a number of multivariate models using logistic regression to control for factors used as measures of socioeconomic status. In each model, maternal use of aspirin products and/or NSAIDs during pregnancy was linked with significantly increased risk of her infant developing PPHN, minimum OR (9 5%CI)=2,1 (1.3, 3.4). These data may have important implicat ions regarding future prevention of PPHN.
pediatrics
What problem does this paper attempt to address?